EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CHIP In cardiovascular and immune ageing

Harish C Chandramoorthy, Muhammad Afzal, Haider Ali, Kavita Goyal, Vikas Jakhmola, Gaurav Gupta, Ayidh Mohammed Safar Alsalem, Kumarappan Chidambaram

Ageing Research Reviews · 2026-08 · 120 · 103214

DOI: 10.1016/j.arr.2026.103214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-08. Verfasst von Harish C Chandramoorthy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Clinical Parasitology, College of Medicine, Stem Cell Research Lab, Medical and Biological Sciences Unit, Central Core R…. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Aging, Cardiovascular Diseases, Immunosenescence. Die Arbeit nennt 178 Literaturangaben. Gefördert von: King Khalid University, King Khalid University Deanship of Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis of indeterminate potential (CHIP) describes the proliferation of blood cell clones that carry driver mutations, such as DNA methyltransferase 3 alpha (DNMT3A), ten-eleven translocation 2 (TET2), additional sex combs like 1 (ASXL1), and Janus kinase 2 (JAK2), without leading to any obvious malignancy. Its occurrence rate is age-related and associated with cardiovascular and immune aging. In prospective cohort studies, CHIP substantially elevated the risk of myocardial infarction, stroke, and heart failure, with a relative risk increase ranging from 1.4 to 2.0-fold. Furthermore, a larger clone size, as indicated by the variant allele fraction (VAF), is correlated with a heightened risk. Both experimental and human evidence support the association of proinflammatory myeloid reprogramming with the loss of ten-eleven translocation 2 (TET2)/DNA methyltransferase 3 alpha (DNMT3A), NOD-like receptor family pyrin domain-containing 3 (NLRP3), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) signaling, as well as endothelial dysfunction and atherothrombosis. However, the effect sizes vary depending on the specific gene, tissue, and context, and residual confounding remains a concern. This paper reviews the epidemiology and pathophysiology of the disease, its clinical utility, including indications for testing, interpretation of variants, VAF levels, and the added value to conventional risk models and treatment methods, such as cytokine- and mutation-based approaches. Priority areas include genotype- and VAF-stratified trials that focus on outcomes relevant to aging and are rigorously monitored for their safety. Overall, CHIP is associated with somatic mosaicism, inflammaging, and aging of the cardiovascular and immune systems, although significant questions regarding causation and actionability remain unresolved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisAgingCardiovascular DiseasesImmunosenescenceHumansAnimalsMutation

Stichwörter der Autor:innen

CHIPCardiovascular AgingImmune AgingInflammagingNLRP3 inflammasomeVAF

Autor:innen und Institutionen

  • Department of Microbiology & Clinical Parasitology, College of Medicine, Stem Cell Research Lab, Medical and Biological Sciences Unit, Central Core Research Laboratories, King Khalid University, Abha, Saudi Arabia.
  • Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
  • Sharda University, Greater Noida, India.
  • Dept. of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India.
  • Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India.
  • Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.

Förderung

  • King Khalid University
  • King Khalid University Deanship of Scientific Research

Zitieren

APA

Chandramoorthy, H. C., Afzal, M., Ali, H., Goyal, K., Jakhmola, V., Gupta, G., Alsalem, A. M. S., & Chidambaram, K. (2026). CHIP In cardiovascular and immune ageing. Ageing Research Reviews, 120, 103214. https://doi.org/10.1016/j.arr.2026.103214

Vancouver

Chandramoorthy HC, Afzal M, Ali H, Goyal K, Jakhmola V, Gupta G, et al. CHIP In cardiovascular and immune ageing. Ageing Research Reviews. 2026;120:103214. doi:10.1016/j.arr.2026.103214

BibTeX
@article{Chandramoorthy2026,
  author = {Chandramoorthy, Harish C and Afzal, Muhammad and Ali, Haider and Goyal, Kavita and Jakhmola, Vikas and Gupta, Gaurav and Alsalem, Ayidh Mohammed Safar and Chidambaram, Kumarappan},
  title = {CHIP In cardiovascular and immune ageing},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {120},
  pages = {103214},
  doi = {10.1016/j.arr.2026.103214}
}
Kostenlos starten →